NATX Plasmids, for: DNA Vaccines, Gene Therapeutics, Viral Vectors andBiophamacueticals

Research and Development
Partnering Opportunities

NTC Contacts:
Phone: (402) 323-6289 (natx)
Fax: (402) 323-6292
Email: support@natx.com

site map | home | contact us
NTC PRODUCTS AND SERVICES

MAMMALIAN EXPRESSION VECTORS
X• Antibiotic-Free Vectors
X• Rig-I Activating Vectors
X• Linear Vectors
X• Recombineering Vectors
X• Gene Silencing (transient)
X• Gene Silencing (retroviral, stable)
X• Anti-Silencing Elements
X• Vector Pricing

CELL LINES
X• Autolytic E. coli Cell Lines
X• dcm- Strains

VACCINES & ADJUVANTS
X• DNA Vaccines
X• Rig-I Activating DNA Vaccines
X• Thermostable Protein Expression

PRECISION CLONING
X• Services and Pricing

RECOMBINANT PROTEINS
X• pVEX™-E. coli Expression Vectors
X• Fluorescent Proteins
X• Products, Vectors, Services, Prices
X• CofA (SAMPLE)

PLASMIDS
X• Small Scale Plasmid DNA
X• Small Scale C of A
X• Large Scale Plasmid DNA
X• Large Scale C of A
X• Plasmid DNA Order Form
X• E. coli Cell paste
X• NEW! Plasmid Detox Service
X• Additional Testing

PROCESS DEVELOPMENT

DNA FERMENTATION PROCESS
X• HyperGRO™ Publications
X• E. coli Cell Paste

HYPERTAQ™ DNA POLYMERASE

CONTRACT QC
X• E. coli Genomic DNA Testing
X• Residual RNA qPCR
X• Residual RNA gel
X• Supercoil Assay
X• Lymulus Endotoxin Testing


Gene Therapeutics and DNA Vaccines Development (Partnering opportunity)

NTC is a leader in non-viral vector development, providing key enabling technologies for direct DNA therapies, including:  

• Enhanced mammalian plasmid expression vectors

• RIG-I mediated innate immunity activation for DNA vaccines;

• Advanced host strains for modulating pDNA methylation;

• Antibiotic free plasmid propagation;

• PAS-BH highest copy plasmid replicon for superior, economical production in E. coli;

• Translational enhancers;

• Improved promoters;

• Antisilencing elements;

• Regulatory compliant vectors; and

• HyperGRO fermentation process for highest production yields in E. coli.





NTC is seeking partners with lead therapeutic and immunologic targets and/or novel delivery systems.  NTC will provide vectors with partners’ genes of choice, fully optimized, constructed and purified, ready for preclinical use in animals - in about a month.


Call NTC today to discuss your upcoming biopharmaceutical development projects.

NTC Contact:
Phone: (402) 323-6289 (natx)
Fax: (402) 323-6292